Maxim Group Upgrades Gilead Sciences (GILD) to Buy
Maxim Group analyst Jason McCarthy upgraded Gilead Sciences (NASDAQ: GILD) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)